| Title | Author(s) | Year | View Count |
 | CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant | Kang, Y; Wu, Z; Lau, TCK; Lu, X; Liu, L; Cheung, AKL; Tan, Z; Ng, J; Liang, J; Wang, H; Li, S; Zheng, B; Li, B; Chen, L; Chen, Z | 2012 | 101 |
| F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis | Lu, X; Liu, L; Zhang, X; Lau, TCK; Tsui, SKW; Kang, Y; Zheng, P; Zheng, B; Liu, G; Chen, Z | 2012 | 97 |
| Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis | Siu, GKH; Zhang, Y; Lau, TCK; Lau, RWT; Ho, PL; Yew, WW; Tsui, SKW; Cheng, VCC; Yuen, KY; Yam, WC | 2011 | 70 |
| Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: Functional analysis of gyrA mutation at position 74 | Lau, RWT; Ho, PL; Kao, RYT; Yew, WW; Lau, TCK; Cheng, VCC; Yuen, KY; Tsui, SKW; Chen, X; Yam, WC | 2011 | 89 |
|
